High OX40 expression in recurrent ovarian carcinoma is indicative for response to repeated chemotherapy

Overview of attention for article published in BMC Cancer, April 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 27 Dimensions

Readers on

mendeley: 32 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Antibodies or antigen-binding fragments that bind to OX40

Grant US-11879015-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.